Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India

Hemodialysis International

Volumn 9, Issue 1, 2005, Pages 63-67

  Sankarasubbaiyan, Suresh ^a   Abraham, Georgi ^b   Soundararajan, P ^b   Chandrasekaran, V ^c   Padma, G ^c  

^a Sundaram Medical Foundation   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

^c MADRAS MEDICAL COLLEGE   (India)

Author keywords

Ethnic; Hyperphosphatemia; Renal osteodystrophy; Secondary hyperparathyroidism; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CALCITRIOL; CALCIUM; CALCIUM ACETATE; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; ARTICLE; BONE TURNOVER; CHEMICAL PARAMETERS; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIET; ETHNIC DIFFERENCE; FEMALE; GENETIC POLYMORPHISM; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; INDIA; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM; TROPIC CLIMATE;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BONE DISEASES; FEMALE; HUMANS; INDIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PERITONEAL DIALYSIS; RENAL OSTEODYSTROPHY; SEX FACTORS;

EID: 21644446961     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1492-7535.2005.01119.x     Document Type: Article

References (15)

1. Remiss G, Schlepped A, Pierce N. Preventing end-stage renal disease: The potential impact of screening and intervention in developing countries. Nephrol Dial Transplant. 2003; 18:858-859.
2. Schema FP. Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy. Kidney Int. 2000; 57(Suppl 74):S39-S45.
3. Kher V. End-stage renal disease in developing countries. Kidney Int. 2002; 62(1):350-362.
4. Dash SC, Agarwal SK. Spectrum of renal diseases in Indian adults. J Assoc Physicians India. 2000; 46(6): 594-600.
5. Hruska K, Teitelbaum SL. Renal osteodystrophy. N Engl J Med. 1995; 333(3):166-174.
6. Sherrad DJ, Gercz GH, York P, Maloney N, Greenwood C, Manuel A, Saiphoo C, Fenton S, Segre G. The spectrum of bone disease in end stage renal failure. Kidney Int. 1993; 43:436-442.
7. Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, Fenton C, Sherrad D. Renal osteodystrophy in diabetic patients. Kidney Int. 1993; 44(1):159-164.
8. Goodman W, Ramreis J, Belin T, Chon Y, Gales B, Serge G, Salusky I. Development of adynamic bone disease in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int. 1994; 46: 1160-1166.
9. Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol. 2000; 11(2): 330-334.
10. Shin SK, Kim DH, Kim HS, Shin TS, Ma KA, Kim SJ, Kwak YS, Ha SK, Sherrad DJ. Renal osteodystrophy in predialysis patients: Ethnic difference. Perit Dial Int. 1999; 19:S402-S407.
11. Country health profile-India [Internet]. New Delhi: World Health Organization; c2004. Available from: http://w3.whosea.org/cntryhealth/india/index.htm.
12. Rao M, Juneja R, Shirly RB, Jacob CK. Haemodialysis for end-stage renal disease in Southern India - A perspective from a tertiary care centre. Nephrol Dial Transplant. 1998; 13:2494-2500.
13. Ballal HS, Anandh U. Haemodialysis in India. Nephrol Dial Transplant. 1999; 14(11):2779.
14. Singh AK, Avula S, Kher V, Rao DS, Mithal A. Calcitropic hormonal status in north Indian patients with end-stage renal disease. Natl Med J India. 1999; 12(5):202-207.
15. Rao M, Israel J, Krishnaswamy H, Shastry JC, Jacob CK. Renal osteodystrophy in patients with end stage renal disease. Ind J Nephrol. 1993; 3(1):1-3.